Relmada Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $303k | 73k | 4.14 |
| 2023-09-30 | $299k | 100k | 3.00 |
| 2022-12-31 | $646 | 185 | 3.49 |
| 2022-09-30 | $155k | 4.2k | 37.06 |
| 2021-12-31 | $113k | 5.0k | 22.54 |
| 2021-03-31 | $59k | 1.8k | 33.33 |
| 2020-12-31 | $126k | 4.5k | 28.04 |
| 2020-09-30 | $97k | 2.6k | 37.43 |
| 2020-06-30 | $223k | 5.0k | 44.38 |
| 2020-03-31 | $58k | 1.7k | 34.12 |
| 2019-12-31 | $37k | 936 | 39.53 |